|
gptkbp:instanceOf
|
gptkb:beta_blocker
gptkb:drug
|
|
gptkbp:approvedBy
|
1978
|
|
gptkbp:ATCCode
|
C07AB02
|
|
gptkbp:availableOn
|
succinate salt
tartrate salt
|
|
gptkbp:bioavailability
|
40-50%
|
|
gptkbp:brand
|
Lopressor
Toprol-XL
|
|
gptkbp:CASNumber
|
37350-58-6
|
|
gptkbp:category
|
selective beta-1 blocker
|
|
gptkbp:chemicalFormula
|
C15H25NO3
|
|
gptkbp:contraindication
|
asthma
severe bradycardia
cardiogenic shock
|
|
gptkbp:discoveredBy
|
gptkb:AstraZeneca
|
|
gptkbp:eliminationHalfLife
|
3-7 hours
|
|
gptkbp:excretion
|
gptkb:kidney
|
|
gptkbp:interactsWith
|
gptkb:rifampin
gptkb:SSRIs
gptkb:clonidine
gptkb:digoxin
cimetidine
calcium channel blockers
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
beta-1 adrenergic receptor antagonist
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
267.36 g/mol
|
|
gptkbp:pregnancyCategory
|
C (US)
B3 (Australia)
|
|
gptkbp:proteinBinding
|
12%
|
|
gptkbp:PubChem_CID
|
4171
DB00264
|
|
gptkbp:routeOfAdministration
|
oral
intravenous
|
|
gptkbp:sideEffect
|
gptkb:depression
dizziness
fatigue
hypotension
bradycardia
|
|
gptkbp:synonym
|
metoprolol succinate
metoprolol tartrate
|
|
gptkbp:UNII
|
GQB5M1WPNF
|
|
gptkbp:usedFor
|
gptkb:angina
heart failure
myocardial infarction
hypertension
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
true
|
|
gptkbp:bfsParent
|
gptkb:Seloken
gptkb:C07AB03
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
metoprolol
|